RSV Prefusion F Protein–Based Maternal Vaccine—Preterm Birth and Other Outcomes
(Abstracted from N Engl J Med 2024;390:1009–1021) Respiratory syncytial virus (RSV), a major cause of lower respiratory tract disease in young children, disproportionately affects infants <6 months of age. Effective treatments are needed to prevent the disease.
Authors
- Wenji Pu (ORCID: https://orcid.org/0009-0009-5259-8183)
- P. Webster (ORCID: https://orcid.org/0000-0003-2784-0029)
- Philip R. Dormitzer (ORCID: https://orcid.org/0000-0003-0671-6360)
- Ilse Dieussaert (ORCID: https://orcid.org/0000-0001-8158-8819)
- Cláudia Seidl (ORCID: https://orcid.org/0000-0001-8264-3402)
- Geeta K. Swamy (ORCID: https://orcid.org/0000-0001-5092-6993)
- Sabine Luik
- Joon Hyung Kim (ORCID: https://orcid.org/0000-0002-6014-3543)
- Jens Ulrich Stegmann
Institutions
- United States Department of the Army (US)
- WWF Tanzania (TZ)
- R&D Systems (United States) (US)
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/01.ogx.0001069180.38902.d0
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00